Targeted Imaging of Lung Cancer with Hyperpolarized (129)Xe MRI Using Surface-Modified Iron Oxide Nanoparticles as Molecular Contrast Agents

SIMPLE SUMMARY: Hyperpolarized (129)Xe (HP (129)Xe) MRI was used to demonstrate the feasibility of targeted imaging of lung cancer using two cancer-specific surface-modified iron oxide nanoparticles (IONPs) as negative contrast agents; polyethylene glycol-coated IONPs (PEG-IONPs), and dextran-coated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Atsuomi, Utsumi, Seiya, Shimokawa, Akihiro, Nishimori, Renya, Hosoi, Rie, Stewart, Neil J., Imai, Hirohiko, Fujiwara, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776850/
https://www.ncbi.nlm.nih.gov/pubmed/36551556
http://dx.doi.org/10.3390/cancers14246070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776850/
https://www.ncbi.nlm.nih.gov/pubmed/36551556
http://dx.doi.org/10.3390/cancers14246070

Ejemplares similares